Strijk, Gaby J.
van Diepen, Aniek E.
Wilmink, Johanna W.
Rietjens, Judith A. C.
Haberkorn, Brigitte C. M.
Stiggelbout, Anne M.
Homs, Marjolein Y. V.
de Vos-Geelen, Judith
van Eijck, Casper H. J.
van Eijck, Casper W. F.
Funding for this research was provided by:
the Survival with Pancreatic Cancer Foundation (OVIT17-06)
the Survival with Pancreatic Cancer Foundation (OVIT17-06)
the Survival with Pancreatic Cancer Foundation (OVIT17-06)
Article History
Received: 6 August 2024
Revised: 4 March 2026
Accepted: 10 March 2026
First Online: 26 March 2026
Declarations
:
: The participants in this study originated from the iKnowIT prospective cohort study (Dutch trial register NL7522). The iKnowIT study adhered to the Declaration of Helsinki and was approved in February 2019 by the Ethics Committees of the Erasmus MC (MEC-2018–087), the Amsterdam University Medical Centre (L18-053), and Maasstad Hospital (L2018095) in the Netherlands. Written informed consent was obtained from all patients.
: The authors declare no competing interests.